Which is better, APLS or HALO?

APLS and HALO tie on the headline Buffett-Fit score (58/100 each). The decision comes down to which underlying framework you trust most — APLS leads on Philip Fisher, Peter Lynch, and Joel Greenblatt; HALO leads on Warren Buffett, Benjamin Graham, Charlie Munger, and Terry Smith. The pillar-by-pillar breakdown is on this page.

Should I buy APLS or HALO?

This page is an educational comparison, not investment advice. Both APLS and HALO are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is APLS better than HALO for value investing?

On the Buffett-style value-investing framework, HALO currently grades higher — 79/100 vs 58/100, a 21-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between APLS and HALO on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). APLS currently scores 58/100 (C grade); HALO scores 79/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, APLS or HALO?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. APLS and HALO are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, APLS or HALO?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are APLS and HALO both Healthcare stocks?

Yes — both Apellis Pharmaceuticals, Inc. (APLS) and Halozyme Therapeutics, Inc. (HALO) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this APLS vs HALO comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Apellis Pharmaceuticals

Halozyme Therapeutics

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

APLS

Market cap

$5.25B

Sector

Healthcare

HALO

Halozyme Therapeutics

Market cap

$8.1B

Sector

Healthcare

Fit scores by strategy

Strategy	APLS	HALO	Winner
Warren Buffett	58C	79B	HALO
Benjamin Graham	79D	83A	HALO
Philip Fisher	71C	65B	APLS
Peter Lynch	81C	53D	APLS
Joel Greenblatt	63C	40D	APLS
Charlie Munger	67D	80C	HALO
Terry Smith	65B	84A	HALO

Side-by-side metrics

Metric	APLS	HALO
Market cap	$5.25B	$8.1B
P/E (TTM)	38.8x	24.0x
EV/EBIT	96.0x	10.2x
ROIC (TTM)	18.11%	23.65%
Gross margin	90.12%	81.24%
Net margin	12.06%	23.13%
Revenue CAGR 5y	97.06%	33.23%
EPS CAGR 5y	-	-1.98%
Debt / Equity	1.1x	1.0x
Dividend yield	0.0%	0.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

APLS leads on

Revenue CAGR 5y97.06%vs 33.23%+66%
Gross margin90.12%vs 81.24%+10%

HALO leads on

EV/EBIT10.2xvs 96.0x+89%
Net margin23.13%vs 12.06%+48%
P/E (TTM)24.0xvs 38.8x+38%
Market cap$8.1Bvs $5.25B+35%

More like APLS

APLS vs IDXX APLS vs 7741.T APLS vs GMAB APLS vs LMAT APLS vs SUNPHARMA.NS APLS vs MTD

More like HALO

HALO vs IDXX HALO vs 7741.T HALO vs GMAB HALO vs LMAT HALO vs SUNPHARMA.NS HALO vs MTD

Read the full Buffett-Brain analysis for APLS Read the full Buffett-Brain analysis for HALO

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Stock comparison

Apellis Pharmaceuticals

Halozyme Therapeutics

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

APLS

Apellis Pharmaceuticals

Market cap

$5.25B

Sector

Healthcare

HALO

Halozyme Therapeutics

Market cap

$8.1B

Sector

Healthcare

Fit scores by strategy

Strategy	APLS	HALO	Winner
Warren Buffett	58C	79B	HALO
Benjamin Graham	79D	83A	HALO
Philip Fisher	71C	65B	APLS
Peter Lynch	81C	53D	APLS
Joel Greenblatt	63C	40D	APLS
Charlie Munger	67D	80C	HALO
Terry Smith	65B	84A	HALO

Side-by-side metrics

Metric	APLS	HALO
Market cap	$5.25B	$8.1B
P/E (TTM)	38.8x	24.0x
EV/EBIT	96.0x	10.2x
ROIC (TTM)	18.11%	23.65%
Gross margin	90.12%	81.24%
Net margin	12.06%	23.13%
Revenue CAGR 5y	97.06%	33.23%
EPS CAGR 5y	-	-1.98%
Debt / Equity	1.1x	1.0x
Dividend yield	0.0%	0.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

APLS leads on

Revenue CAGR 5y97.06%vs 33.23%+66%
Gross margin90.12%vs 81.24%+10%

HALO leads on

EV/EBIT10.2xvs 96.0x+89%
Net margin23.13%vs 12.06%+48%
P/E (TTM)24.0xvs 38.8x+38%
Market cap$8.1Bvs $5.25B+35%

More like APLS

APLS vs IDXX APLS vs 7741.T APLS vs GMAB APLS vs LMAT APLS vs SUNPHARMA.NS APLS vs MTD

More like HALO

HALO vs IDXX HALO vs 7741.T HALO vs GMAB HALO vs LMAT HALO vs SUNPHARMA.NS HALO vs MTD

Read the full Buffett-Brain analysis for APLS Read the full Buffett-Brain analysis for HALO

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.